Aprendizaje cooperativo y fundamentos técnicos del voleibol en los estudiantes del 3er grado del nivel secundario de la institución educativa privada San Marcos del Cusco - 2024

Esta investigación se dedica a desentrañar el arte del aprendizaje cooperativo y las bases técnicas del voleibol entre los alumnos de tercer año de secundaria en la escuela privada San Marcos en Cusco en el año 2024. El objetivo principal del estudio fue investigar cómo los alumnos de tercer año de secundaria en la escuela privada San Marcos del Cusco en el año 2024 practican voleibol en grupos para mejorar sus habilidades. En la investigación se tomó la muestra a 30 alumnos. La metodología fue la investigación de tipo básica, de nivel descriptivo-correlacional y el diseño fue no experimental-transversal. Se usó un instrumento de autoevaluación y una ficha de observación para la recaudación de datos. Se observó que mediante la prueba de normalidad Shapiro-Wilk la distribución de datos son no normales, pero mediante la prueba de rango de coeficiente de Spearman se determinó unos resultados significativamente positivos. La pesquisa evidencia coeficientes de correlación de Spearman (rho) de 0.758, evidenciando una relación positiva y relevante del aprendizaje cooperativo y cada fundamento del vóley. Este resultado sugiere que los aprendizajes cooperativos se encuentran estrechamente relacionado con la mejora en la adquisición de cada fundamento técnico del vóley en los alumnos

Report of the Evidence and Conclusions of the Committee to Investigate the Sale of the Agricultural College Scrip

A transcript of the testimony and evidence presented at legislative hearings made to the fifty-fifth legislature in 1876 to investigate the sale of Maine\u27s land grant scrip at a price far below the market rates for such property

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence

<p>Abstract</p> <p>Background</p> <p>During the last decade, pharmaceutical spending for patients with attention-deficit-hyperactivity disorder (ADHD) has been escalating internationally.</p> <p>Objectives</p> <p>First, to estimate future trends of ADHD-related drug expenditures from the perspectives of the statutory health insurance (SHI; Gesetzliche Krankenversicherung, GKV) in Germany and the National Health Service (NHS) in England, respectively, for children and adolescents age 6 to 18 years. Second, to evaluate the budgetary impact on individual prescribers (child and adolescent psychiatrists and pediatricians treating patients with ADHD) in Germany.</p> <p>Methods</p> <p>A model was developed to predict plausible scenarios of future pharmaceutical expenditures for treatment of ADHD. Model inputs were derived from demographic and epidemiological data, a literature review of past spending trends, and an analysis of new pharmaceutical products in development for ADHD. Only products in clinical development phase III or later were considered. Uncertainty was addressed by way of scenario analysis. For each jurisdiction, five scenarios used different assumptions of future diagnosis prevalence, treatment prevalence, rates of adoption and unit costs of novel drugs, and treatment intensity.</p> <p>Results</p> <p>Annual ADHD pharmacotherapy expenditures for children and adolescents will further increase and may exceed €310 m (D; E: ₤78 m) in 2012 (2002: ~€21.8 m; ~₤7.0 m). During this period, overall drug spending by individual physicians may increase 2.3- to 9.5-fold, resulting from the multiplicative effects of four variables: increased number of diagnosed cases, growing acceptance and intensity of pharmacotherapy, and higher unit costs of novel medications.</p> <p>Discussion</p> <p>Even for an extreme low case scenario, a more than six-fold increase of pharmaceutical spending for children and adolescents is predicted over the decade from 2002 to 2012, from the perspectives of both the NHS in England and the GKV in Germany. This budgetary impact projection represents a partial analysis only because other expenditures are likely to rise as well, for instance those associated with physician services, including diagnosis and psychosocial treatment. Further to this, by definition budgetary impact analyses have little to nothing to say about clinical appropriateness and about value of money.</p> <p>Conclusion</p> <p>Providers of care for children and adolescents with ADHD should anticipate serious challenges related to the cost-effectiveness of interventions.</p

Drug delivery systems

SIGLEGBUnited Kingdo

Pain management Current perspectives and markets

SIGLEGBUnited Kingdo

Antibacterials

SIGLEAvailable from British Library Document Supply Centre- DSC:8211.859533(1993) / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Japanese pharmaceuticals A special report by Scrip

SIGLELD:f82/3318 / BLDSC - British Library Document Supply CentreGBUnited Kingdo